Geographic variations in incremental costs of heart disease among medicare beneficiaries, by type of service, 2012

Similar documents
2012 Medicaid and Partnership Chart

Prevalence of Self-Reported Obesity Among U.S. Adults by State and Territory. Definitions Obesity: Body Mass Index (BMI) of 30 or higher.

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

Obesity Trends:

Cirrhosis and Liver Cancer Mortality in the United States : An Observational Study Supplementary Material

ACEP National H1N1 Preparedness Survey Results

National Deaf Center on Postsecondary Outcomes. Data Interpretation Guide for State Reports: FAQ

Peer Specialist Workforce. State-by-state information on key indicators, and links to each state s peer certification program web site.

The Rural Health Workforce. Policy Brief Series. Data and Issues for Policymakers in: Washington Wyoming Alaska Montana Idaho

Responses to a 2017 Survey on State Policies Regarding Community Health Workers: Home Visiting to Improve the Home Environment

2018 HPV Legislative Report Card

Using Policy, Programs, and Partnerships to Stamp Out Breast and Cervical Cancers

DEPARTMENT OF DEFENSE (AFHSB)

Medical Advisory Board. reviews medical issues for licensure regarding individual drivers. medical conditions. not specified. reporting encouraged,

Percent of U.S. State Populations Covered by 100% Smokefree Air Laws April 1, 2018

DEPARTMENT OF DEFENSE (AFHSB)

STATE RANKINGS REPORT NOVEMBER mississippi tobacco data

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB) Seasonal Influenza Surveillance Summary Northern Command -- Week 17 (22 Apr 28 Apr 2018)

DEPARTMENT OF DEFENSE (AFHSB)

Exhibit 1. Change in State Health System Performance by Indicator

Forensic Patients in State Hospitals:

Medical Marijuana Responsible for Traffic Fatalities Alfred Crancer, B.S., M.A.; Phillip Drum, Pharm.D.

Hospice Metrics Using Medicare Data to Measure Access and Performance for Hospice and Palliative Care

States with Authority to Require Nonresident Pharmacies to Report to PMP

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

Analysis of State Medicaid Agency Performance in Relation to Incentivizing the Provision of H1N1 Immunizations to Eligible Populations

DEPARTMENT OF DEFENSE (AFHSB)

April 25, Edward Donnell Ivy, MD, MPH

Geographical Accuracy of Cell Phone Samples and the Effect on Telephone Survey Bias, Variance, and Cost

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

Perinatal Health in the Rural United States, 2005

MetLife Foundation Alzheimer's Survey: What America Thinks

Average Number Citations per Recertification Survey

An Unhealthy America: The Economic Burden of Chronic Disease Charting a New Course to Save Lives and Increase Productivity and Economic Growth

The Healthy Indiana Plan

DEPARTMENT OF DEFENSE (AFHSB)

DEPARTMENT OF DEFENSE (AFHSB)

Georgina Peacock, MD, MPH

DEPARTMENT OF DEFENSE (AFHSB)

The Chiropractic Pediatric CE Credit Program with Emphasis on Autism

HIV/AIDS and other Sexually Transmitted Diseases (STDs) in the Southern Region of the United States: Epidemiological Overview

Instant Drug Testing State Law Guide

HIV in Prisons, 2000

West Nile virus and other arboviral activity -- United States, 2013 Provisional data reported to ArboNET Tuesday, January 7, 2014

AAll s well that ends well; still the fine s the crown; Whate er the course, the end is the renown. WILLIAM SHAKESPEARE, All s Well That Ends Well

Opioid Deaths Quadruple Since 1999

Plan Details and Rates. Monthly Premium Rate Schedule

MAKING WAVES WITH STATE WATER POLICIES. Washington State Department of Health

NCQA did not add new measures to Accreditation 2017 scoring.

Trends in COPD (Chronic Bronchitis and Emphysema): Morbidity and Mortality. Please note, this report is designed for double-sided printing

SUMMARY OF SYNTHETIC CANNABINOID BILLS

Methamphetamines: A National and State Crisis. Research Brief. Prepared by

West Nile virus and other arboviral activity -- United States, 2016 Provisional data reported to ArboNET Tuesday, October 11, 2016

Results from the Commonwealth Fund Scorecard on State Health System Performance. Douglas McCarthy. Senior Research Director The Commonwealth Fund

Save Lives and Money. Help State Employees Quit Tobacco

March 5, The Honorable John A. Boehner Speaker U.S. House of Representatives H-232 U.S. Capitol Building Washington, DC 20515

It's tick time again! Recognizing black-legged (deer ticks) and measuring the spread of Lyme disease

Health Care Reform: Colorectal Cancer Screening Expansion, Before and After the Affordable Care Act (ACA)

Opioid Abuse and Dependence. A National Tapestry of Care and Cost with a State-by-State Analysis

September 20, Thomas Scully Administrator Centers for Medicare and Medicaid Services 200 Independence Avenue SW Washington, DC 20201

The 2004 National Child Count of Children and Youth who are Deaf-Blind

Hawai i to Zero. Timothy McCormick Harm Reduction Services Branch Hawai i Department of Health. January 16, 2018

CDC activities with Autism Spectrum Disorders

PETITION FOR DUAL MEMBERSHIP

Health Care Reform: Colorectal Cancer Screening Disparities, Before and After the Affordable Care Act (ACA)

Chapter Two Incidence & prevalence

B&T Format. New Measures. 2 CAHPS is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ).

-Type of immunity that is more permanent (WBC can Remember)

B&T Format. New Measures. Better health care. Better choices. Better health.

CMS Oral Health Ini9a9ve - Goals

Medical Marijuana

ROAD SAFETY MONITOR. ALCOHOL-IMPAIRED DRIVING IN THE UNITED STATES Results from the 2017 TIRF USA Road Safety Monitor

B&T Format. New Measures. Better health care. Better choices. Better health.

Autism Activities at CDC: The Public Health Model

HIV in Prisons,

Quarterly Hogs and Pigs

Quarterly Hogs and Pigs

If you suspect Fido's owner is diverting prescription pain meds meant for the pet, checking your state's drug monitoring database may not help

The Wellbeing of America s Workforce, and Its Effects on an Organization s Performance

Trends in Lung Cancer Morbidity and Mortality

% $0 $ % $1,954,710 $177, % $0 $ % $0 $ % $118,444 $59, Mississippi

The indicators studied in this report are shaped by a broad range of factors, many of which are determined by

Medicaid represents an important

Contents. Introduction. Acknowledgments. 1 Assisted Reproduction and the Diversity of the Modern Family 1. 2 Intrauterine Insemination 31.

2003 National Immunization Survey Public-Use Data File

CDC activities Autism Spectrum Disorders

October 3, Dear Representative Hensarling:

Hepatitis C: The State of Medicaid Access. Preliminary Findings: National Summary Report

State Medicaid Coverage for Tobacco Cessation Treatments and Barriers to Coverage United States,

Women s health status is one of the strongest determinants of how women use the health care system. The

The FASD Regional Training Centers: What do they offer and what can they do for you?

NM Coalition of Sexual Assault Programs, Inc.

Transcription:

Geographic variations in incremental costs of heart disease among medicare beneficiaries, by type of service, 2012 Rita Wakim, Centers for Disease Control and Prevention Matthew Ritchey, Centers for Disease Control and Prevention Jason Hockenberry, Emory University Michele Casper, Centers for Disease Control and Prevention Journal Title: Preventing Chronic Disease Volume: Volume 13, Number 12 Publisher: Centers for Disease Control and Prevention 2016-12-29, Pages E180-E180 Type of Work: Article Final Publisher PDF Publisher DOI: 10.5888/pcd13.160209 Permanent URL: https://pid.emory.edu/ark:/25593/rwjjd Final published version: http://dx.doi.org/10.5888/pcd13.160209 Copyright information: Copyright 2016 U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention Accessed September 9, 2018 8:21 AM EDT

PUBLIC HEALTH RESEARCH, PRACTICE, AND POLICY Volume 13, E180 DECEMBER 2016 RESEARCH BRIEF Geographic Variations in Incremental Costs of Heart Disease Among Medicare Beneficiaries, by Type of Service, 2012 Rita Wakim, MA 1,2 ; Matthew Ritchey, DPT 1 ; Jason Hockenberry, PhD 2 ; Michele Casper, PhD 1 Suggested citation for this article: Wakim R, Ritchey M, Hockenberry J, Casper M. Geographic Variations in Incremental Costs of Heart Disease Among Medicare Beneficiaries, by Type of Service, 2012. Prev Chronic Dis 2016;13:160209. DOI: https:// doi.org/10.5888/pcd13.160209. PEER REVIEWED Abstract Using 2012 data on fee-for-service Medicare claims, we documented regional and county variation in incremental standardized costs of heart disease (ie, comparing costs between beneficiaries with heart disease and beneficiaries without heart disease) by type of service (eg, inpatient, outpatient, post-acute care). Absolute incremental total costs varied by region. Although the largest absolute incremental total costs of heart disease were concentrated in southern and Appalachian counties, geographic patterns of costs varied by type of service. These data can be used to inform development of policies and payment models that address the observed geographic disparities. Objective Treatment of heart disease is one of the largest drivers of health care costs in the United States, accounting for approximately $273 billion annually (1). Although geographic variation in Medicare costs is well documented (2), little is known about geographic variation in costs for beneficiaries with heart disease. The objective of this study was to document geographic variation in incremental health care costs among fee-for-service Medicare beneficiaries diagnosed with heart disease and costs among beneficiaries without heart disease by region, county, and type of service. Methods We used 2012 data from the Centers for Medicare & Medicaid Services (CMS) Chronic Conditions Data Warehouse, a database with 100% of fee-for-service Medicare enrollment and claims data (3). We limited the data to Medicare beneficiaries aged 65 years or older. We excluded Medicare beneficiaries enrolled in Medicare Advantage or in Medicare Part A only or Part B only. Beneficiaries with diagnosed heart disease were identified according to the following CMS Hierarchical Condition Category codes: congestive heart failure (code 80), acute myocardial infarction (code 81), unstable angina/acute ischemic heart disease (code 82), and specified heart arrhythmias (code 92). Hierarchical Condition Category codes were created by CMS to predict patient costs and map diagnostic codes into diagnostic groupings (4). All major ICD-9- CM (International Classification of Diseases, Ninth Revision, Clinical Modification) codes for heart disease are included in the HCC except codes 390 398 (acute and chronic rheumatic fever). We calculated total costs by summing Medicare payments, beneficiary payments, and third-party payments for the following service categories: inpatient, outpatient, post-acute care, hospice, physician, procedure/imaging, and other. Because calculating costs incurred directly for heart disease care is not possible, we calculated incremental costs incurred among beneficiaries with heart disease above and beyond the costs incurred by beneficiaries without heart disease. Incremental costs were calculated as the difference between mean annual costs per capita for beneficiaries with heart disease and beneficiaries without heart disease in 2 ways: 1) as the absolute difference, by subtracting the cost per beneficiary without heart disease from the cost per beneficiary with heart disease, and 2) as the relative difference, by dividing the cost per beneficiary with heart disease by the cost per beneficiary without heart disease. Incremental costs were age-standardized (2000 standard US population age 65 years or older) and analyzed by region, county, and type of service. We generated county-level maps of the prevalence of heart disease and the age-standardized The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, www.cdc.gov/pcd/issues/2016/16_0209.htm Centers for Disease Control and Prevention 1

absolute incremental values for total costs, inpatient costs, and outpatient costs of heart disease. Subnational cost analyses were adjusted to eliminate geographic differences in payment rates (eg, local wages, input prices) (5). We used SAS version 9.4 (SAS Institute Inc) for the analyses. Results Total costs among beneficiaries with heart disease was approximately $96 billion in 2012. The absolute and relative incremental total costs of heart disease per beneficiary were $10,345 and 2.6 per capita, respectively. Inpatient, post-acute care, and outpatient services accounted for the vast proportion of total absolute incremental costs (37%, 25%, and 18%, respectively). Relative incremental costs of heart disease varied minimally by region (ranges, 2.5 2.7 for total costs and 1.5 3.0 per service type) (Table). However, absolute incremental total costs varied by region, and the pattern of variation was similar to that of heart disease prevalence (Figure). The highest mean absolute incremental total costs were in the South ($11,581 per capita). The highest mean incremental inpatient costs were also in the South ($4,101 per capita), but the highest mean incremental outpatient costs were in the Midwest ($2,225 per capita). This pattern was further elucidated at the county level. Counties with incremental total costs in the highest quintile (range, $12,443 $28,001) were concentrated primarily in the South and parts of Appalachia (Map A). The highest incremental inpatient costs (highest quintile range, $4,648 $19,329) were in counties in the South and Northeast, including Appalachia (Map C), whereas the highest incremental outpatient costs (top quintile range, $2,363 $7,798) were concentrated primarily in counties in the West and Midwest (Map D). Figure. Incremental costs of care and prevalence of diagnosed heart disease for fee-for-service Medicare beneficiaries by county, 2012. A. Total incremental costs of care. Seven counties had negative incremental values. B. Prevalence of diagnosed heart disease. C. Incremental costs for inpatient services. Nineteen counties had negative incremental values. D. Incremental costs for outpatient services. Ten counties had negative incremental values. All counties with negative incremental values had fewer than 30 beneficiaries with heart disease. Beneficiaries with diagnosed heart disease were identified according to the following Centers for Medicare & Medicaid Services Hierarchical Conditions Category codes: congestive heart failure (80), acute myocardial infarction (81), unstable angina/acute ischemic heart disease (82), and specified heart arrhythmias (92). Incremental costs were calculated as the difference between the mean annual costs per capita for beneficiaries with heart disease and the mean annual costs per capita for beneficiaries without heart disease. For all maps, the category Insufficient data indicates that data from counties with fewer than 10 Medicare beneficiaries were suppressed. Data source: Centers for Medicare & Medicaid Services (5). We used ESRI s ArcGIS 10.3 software to produce the maps. Discussion We found substantial absolute incremental costs of heart disease among fee-for-service Medicare beneficiaries. Inpatient, postacute care, and outpatient services contributed most to incremental costs. Although the highest absolute incremental total costs of heart disease were concentrated in counties in the Southeast and Appalachia, geographic patterns of cost varied by type of service. For example, counties in the South and southern Appalachia generally had the highest absolute incremental inpatient costs but the lowest absolute incremental outpatient costs. Researchers disagree on which factors drive the regional variation in health care costs among Medicare beneficiaries. Among these factors are the need for medical care (eg, determined by the prevalence or severity of disease or prevalence of comorbid condi- 2 Centers for Disease Control and Prevention www.cdc.gov/pcd/issues/2016/16_0209.htm

tions) and the provision of care (6,7). Our findings expand on previous research by describing geographic variation in incremental costs of heart disease and offer initial insights into how differences in the use of services might drive some of this variation. Regions with the highest total incremental costs had the highest heart disease prevalence and highest incremental inpatient costs. At first glance, these patterns suggest that these regions may have had a higher prevalence of severe heart disease or heart disease related comorbidities, which necessitated increased use of higher-cost, higher-acuity care. However, regions with the highest total incremental costs tended to have the lowest outpatient incremental costs and the lowest overall outpatient costs, patterns not necessarily congruent with managing a population with greater health care needs. Perhaps practice patterns in these regions lead to substituting more costly inpatient services for outpatient services. One limitation of this study was the use of claims data rather than clinical data to identify beneficiaries with heart disease. However, claims data are reliable in assessing cardiovascular outcomes (8). Also, standardized payments do not adjust for health status or several sociodemographic factors; these factors may contribute to differences in service use. Geographic variation in the incremental costs of care for beneficiaries with heart disease and geographic differences in use of services suggest a non-uniform use of resources to prevent and treat heart disease. Public health, health care systems, and health plans can use these findings to inform development of policies and payment models that address geographic disparities in service use and overall costs for care among Medicare beneficiaries with heart disease. Acknowledgments We thank Soyoun Park, Elvira McIntyre, and Isaac Nwaise, Division for Heart Disease and Stroke Prevention, Centers for Disease Control and Prevention. This study was funded by the Centers for Disease Control and Prevention. Author Information Corresponding Author: Rita Wakim, MA, Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Hwy NE, Atlanta, GA 30341. Telephone: 770-488-2571. Email: myc5@cdc.gov. Author Affiliations: 1 Division for Heart Disease and Stroke Prevention, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia. 2 Department of Health Policy and Management, Rollins School of Public Health, Emory University, Atlanta, Georgia. References 1. Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, Ezekowitz MD, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011; 123(8):933 44. 2. Newhouse JP, Garber AM. Geographic variation in health care spending in the United States: insights from an Institute of Medicine report. JAMA 2013;310(12):1227 8. 3. Centers for Medicare & Medicaid Services. Chronic conditions data warehouse. http://www.ccwdata.org/index.htm. Accessed May 11, 2016. 4. Ash ASER, Ellis RP, Pope GC, Ayanian JZ, Bates DW, Burstin H, et al. Using diagnoses to describe populations and predict costs. Health Care Financ Rev 2000;21(3):7 28. 5. Centers for Medicare & Medicaid Services. Geographic variation public use file: technical supplement on standardization. 2013. http://www.cms.gov/research- Statistics-Data-and-Systems/Statistics-Trends-and-Reports/ Medicare-Geographic-Variation/index.html. Accessed May 5, 2016. 6. Finkelstein A, Gentzkow M, Williams H. Sources of geographic variation in healthcare: evidence from patient migration. NBER working paper series; 2014. Working paper no. 20789. http://www.nber.org/papers/w20789. Accessed November 1, 2016. 7. Dartmouth Institute for Health Policy and Clinical Practice. The Dartmouth atlas of health care. http:// www.dartmouthatlas.org. Accessed November 1, 2016. 8. Hlatky MA, Ray RM, Burwen DR, Margolis KL, Johnson KC, Kucharska-Newton A, et al. Use of Medicare data to identify coronary heart disease outcomes in the Women s Health Initiative. Circ Cardiovasc Qual Outcomes 2014;7(1):157 62. www.cdc.gov/pcd/issues/2016/16_0209.htm Centers for Disease Control and Prevention 3

Table Table. Prevalence of Heart Disease and Mean Costs per Fee-for-Service Medicare Disease b, Compared With Costs for Beneficiary Without Heart Disease, by US Census Region c, 2012 d Census Region c Total (3,122 counties) a Age-Standardized Prevalence of Heart Disease b, % Beneficiary Without Heart Disease b, $ (% of Total) Mean Absolute Incremental Cost e per Mean Relative Incremental Cost f of Heart Disease b Total 20.4 16,986 (100) 6,641 (100) 10,345 (100) 2.6 Inpatient 5,972 (35) 2,187 (33) 3,785 (37) 2.7 Post-acute care 4,037 (24) 1,427 (21) 2,610 (25) 2.8 Outpatient 2,966 (17) 1,081 (16) 1,885 (18) 2.7 Physician 1,751 (11) 838 (13) 913 (9) 2.1 Hospice 1,057 (6) 356 (5) 701 (7) 3.0 Procedure/imaging 1,016 (6) 665 (11) 351 (3) 1.5 Other 187 (1) 87 (1) 100 (1) 2.1 Northeast (217 counties) Total 20.5 16,848 (100) 6,569 (100) 10,279 (100) 2.6 Inpatient 6,100 (37) 2,098 (32) 4,002 (39) 2.9 Post-acute care 3,732 (22) 1,311 (20) 2,421 (24) 2.8 Outpatient 2,904 (17) 1,134 (17) 1,770 (17) 2.6 Physician 2,053 (12) 985 (15) 1,068 (10) 2.1 Hospice 818 (5) 272 (4) 546 (5) 3.0 Procedure/imaging 1,066 (6) 692 (11) 374 (4) 1.5 Other 175 (1) 77 (1) 98 (1) 2.3 Midwest (1,053 counties) Total 19.5 16,129 (100) 6,360 (100) 9,769 (100) 2.5 Inpatient 5,852 (37) 2,183 (34) 3,669 (38) 2.7 Post-acute care 3,612 (22) 1,274 (20) 2,338 (24) 2.8 Outpatient 3,499 (22) 1,274 (20) 2,225 (22) 2.7 Physician 1,522 (9) 725 (11) 797 (8) 2.1 a 2000 Standard US population age 65 years or older. b Identified according to the following Centers for Medicare & Medicaid Services Hierarchical Condition Category codes: congestive heart failure (code 80), acute myocardial infarction (code 81), unstable angina/acute ischemic heart disease (code 82), and specified heart arrhythmias (code 92). c Northeast includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont. Midwest includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. South includes Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. West includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming. d Data from Centers for Medicare & Medicaid Services Chronic Conditions Data Warehouse (3) limited to Medicare beneficiaries aged 65 years or older; beneficiaries enrolled in Medicare Advantage or in Medicare Part A only or Part B only were excluded. e Calculated by subtracting the cost per beneficiary without heart disease from the cost per beneficiary with heart disease. f Calculated by dividing the age-standardized mean cost per beneficiary with heart disease by the age-standardized mean cost per beneficiary without heart disease. (continued on next page) 4 Centers for Disease Control and Prevention www.cdc.gov/pcd/issues/2016/16_0209.htm

(continued) Table. Prevalence of Heart Disease and Mean Costs per Fee-for-Service Medicare Disease b, Compared With Costs for Beneficiary Without Heart Disease, by US Census Region c, 2012 d Census Region c a Age-Standardized Prevalence of Heart Disease b, % Beneficiary Without Heart Disease b, $ (% of Total) Mean Absolute Incremental Cost e per Mean Relative Incremental Cost f of Heart Disease b Hospice 543 (3) 179 (3) 364 (4) 3.0 Procedure/imaging 922 (6) 626 (10) 296 (3) 1.5 Other 179 (1) 99 (2) 80 (1) 1.8 South (1,417 counties) Total 20.1 18,948 (100) 7,367 (100) 11,581 (100) 2.6 Inpatient 6,421 (34) 2,320 (31) 4,101 (35) 2.8 Post-acute care 4,979 (26) 1,755 (24) 3,224 (28) 2.8 Outpatient 2,659 (14) 980 (13) 1,679 (14) 2.7 Physician 1,962 (10) 945 (13) 1,017 (9) 2.1 Hospice 1,660 (9) 556 (8) 1,104 (10) 3.0 Procedure/imaging 1,089 (6) 712 (10) 377 (3) 1.5 Other 178 (1) 99 (1) 79 (1) 1.8 West (435 counties) Total 17.8 13,953 (100) 5,535 (100) 8,418 (100) 2.5 Inpatient 4,993 (36) 1,913 (35) 3,080 (37) 2.6 Post-acute care 2,791 (20) 976 (18) 1,815 (22) 2.9 Outpatient 3,032 (22) 1,033 (18) 1,999 (23) 2.9 Physician 1,440 (10) 682 (12) 758 (9) 2.1 Hospice 552 (4) 194 (4) 358 (4) 2.8 Procedure/imaging 968 (7) 641 (12) 327 (4) 1.5 Other 177 (1) 96 (1) 81 (1) 1.8 a 2000 Standard US population age 65 years or older. b Identified according to the following Centers for Medicare & Medicaid Services Hierarchical Condition Category codes: congestive heart failure (code 80), acute myocardial infarction (code 81), unstable angina/acute ischemic heart disease (code 82), and specified heart arrhythmias (code 92). c Northeast includes Connecticut, Maine, Massachusetts, New Hampshire, New Jersey, New York, Pennsylvania, Rhode Island, and Vermont. Midwest includes Illinois, Indiana, Iowa, Kansas, Michigan, Minnesota, Missouri, Nebraska, North Dakota, Ohio, South Dakota, and Wisconsin. South includes Alabama, Arkansas, Delaware, District of Columbia, Florida, Georgia, Kentucky, Louisiana, Maryland, Mississippi, North Carolina, Oklahoma, South Carolina, Tennessee, Texas, Virginia, and West Virginia. West includes Alaska, Arizona, California, Colorado, Hawaii, Idaho, Montana, Nevada, New Mexico, Oregon, Utah, Washington, and Wyoming. d Data from Centers for Medicare & Medicaid Services Chronic Conditions Data Warehouse (3) limited to Medicare beneficiaries aged 65 years or older; beneficiaries enrolled in Medicare Advantage or in Medicare Part A only or Part B only were excluded. e Calculated by subtracting the cost per beneficiary without heart disease from the cost per beneficiary with heart disease. f Calculated by dividing the age-standardized mean cost per beneficiary with heart disease by the age-standardized mean cost per beneficiary without heart disease. www.cdc.gov/pcd/issues/2016/16_0209.htm Centers for Disease Control and Prevention 5